Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

With approximately 60% of prescription drugs coming from Europe, including major brands like Ozempic, Botox and Eliquis, many ...

Swiss stocks dropped as the market reopened after a holiday, on worries about the impact from US President Donald Trump’s punitive 39% export tariff and a push for drugmakers to lower prices.

There was one thing everyone agreed on at Monday's listening session on lowering the cost of prescription drugs: Something ...

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...

Also, drug prices haven’t actually come down, despite Trump’s pressure on pharmaceutical companies. Trump appeared to ...

Most of its precision oncology products, including Lorbrena, Braftovi, Mektovi, and Talzenna, posted double-digit increases ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...

Pfizer (PFE) increased its 2025 profit outlook by 10 cents a share to a range of $2.90 to $3.10 a share, citing continued cost cuts, a lower tax rate and "confidence" that strength seen in the first ...

President Donald Trump threatened to levy tariffs of up to 250% on pharmaceuticals imported into the United States.

When you're hit from all sides — by natural disasters, inflation and rising health care costs — you pay attention when ...